Use our peptide array technology, which is built on 25 years of experience, to provide novel insights!
- Therapeutic antibody recognition of SARS-CoV-2 mutations
- Confirming vaccine ability to induce an antibody response against SARS-CoV-2 mutations
- Profiling of main antibody response to canonical SARS-CoV-2 sequences and recent mutations
Schedule a call with our experts for more information:
Dennis Flierman,  PhD – Director of Epitope Mapping
Dennis is an experienced professional with a fundamental biomedical sciences background and experience in immunology, structural biology and biochemistry. He obtained his PhD degree in Biochemistry and Cell Biology and did his PhD work at Harvard Medical University and Penn State University Hershey Medical Center. Next to being in contact with clients Dennis is focussed on data analysis on a daily basis.